awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38398440-D64BAA18-EBAB-4C3D-B9FF-5397857BA0BC
Q38398440-D64BAA18-EBAB-4C3D-B9FF-5397857BA0BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38398440-D64BAA18-EBAB-4C3D-B9FF-5397857BA0BC
ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma.
P2860
Q38398440-D64BAA18-EBAB-4C3D-B9FF-5397857BA0BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38398440-D64BAA18-EBAB-4C3D-B9FF-5397857BA0BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e7790b5aa97d97345961d1d4951371cdaa2def07
P2860
Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy